LA
MEDP icon

Legacy Advisors’s Medpace MEDP Stock Holding History

Legacy Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.43M Sell
4,682
-72
-2% -$24.2K 0.15% 119
2024
Q4 		$1.58M Buy
4,754
+162
+4% +$54.9K 0.15% 103
2024
Q3 		$1.53M Sell
4,592
-155
-3% -$58.9K 0.17% 105
2024
Q2 		$1.96M Buy
4,747
+59
+1% +$23.4K 0.24% 76
2024
Q1 		$1.89M Buy
4,688
+353
+8% +$124K 0.24% 78
2023
Q4 		$1.33M Buy
4,335
+5
+0.1% +$1.35K 0.17% 104
2023
Q3 		$1.05M Buy
4,330
+219
+5% +$56K 0.17% 118
2023
Q2 		$987K Buy
4,111
+194
+5% +$40.3K 0.15% 117
2023
Q1 		$737K Buy
3,917
+85
+2% +$17.6K 0.14% 119
2022
Q4 		$814K Buy
3,832
+706
+23% +$141K 0.15% 103
2022
Q3 		$491K Buy
3,126
+764
+32% +$122K 0.11% 128
2022
Q2 		$354K Buy
+2,362
New +$342K 0.07% 151

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Legacy Advisors's MEDP Position: Q1 2025 in Review

Legacy Advisors reduced its Medpace (MEDP) stake by 1.5% in Q1 2025, selling an estimated $24.2K and leaving 4,682 shares worth $1.43M. The position accounts for 0.15% of the portfolio, ranked #119.

Legacy Advisors first reported a position in MEDP in Q2 2022 and has held it in 12 quarters since. The position peaked at $1.96M in Q2 2024. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

  • Legacy Advisors held 4,682 shares of Medpace worth $1.43M as of Q1 2025.
  • Legacy Advisors sold 72 Medpace shares in Q1 2025, an estimated $24.2K.
  • Medpace made up 0.15% of Legacy Advisors's portfolio in Q1 2025, its #119 holding.
  • Legacy Advisors first reported a position in Medpace in Q2 2022 and has held it in 12 quarters since.
  • Legacy Advisors's Medpace position peaked at $1.96M in Q2 2024.
  • 586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.